DNA repair protein caught in act of molecular theft

DNA repair protein caught in act of molecular theft

Scientists have observed, for the first time, an intermediate stage in the chemical process that repairs DNA methylation damage and regulates many important biological functions that impact health conditions such as obesity, cancer and diabetes.

The observations focused on the bacterial DNA repair protein AlkB, but the results also apply to several proteins in the same family that play key regulatory roles in humans. Armed with these results, researchers may one day develop methods for blocking the protein’s efforts to perform the biologically important demethylation function in human cells, said Chuan He, Professor in Chemistry at the University of Chicago.

“This family of proteins is the most exciting protein family now in biology,” said He, who led the study. “These proteins directly impact obesity, cancer and diabetes, and they do not go through the traditional pathways of DNA or protein modification. Most likely they go through RNA modification and demodification. It’s a new area of biological research.”

He and his colleagues at UChicago and the University of Wisconsin-Madison report their findings in the journal Nature, published online on Nov. 10.

IMAGE: Chuan He, professor in chemistry at the University of Chicago, grows cancer cell lines in his laboratory to study DNA/RNA repair and modification and other important biological processes.
Click here for more information.


The Nature article presents new details about how proteins chemically alter biological molecules and their functioning via a process called oxidative demethylation. Methylation is a chemical process that helps control how DNA and other proteins carry out their functions in the body. In the case of DNA, methylation and demethylation affect how the genetic code gets made into proteins. In recent years scientists had assumed that AlkB and related proteins initiate an oxidizing reaction to remove a hydrocarbon group (the methyls) from the group’s host molecule.

“Biological methylation is one of the most important processes in nature to regulate all kinds of things,” He said, including how cells differentiate into their final state and how genetic information is transmitted to proteins.

The UChicago researchers recently invented a chemical technique to trap the AlkB protein when it reacts with its host molecule — a previously unobserved, ephemeral process. The technique tethers the protein to the host molecule. “It’s stuck there. It can react and stop at the intermediate stage,” He said.

Bizarre Observation

Two of the enzymatic intermediates that He’s team trapped and observed were predicted and expected based on the chemical principles involved, but these fleeting species were directly observed for the first time. For a third intermediate, however, “we observed something bizarre,” He said.

Researchers at UW-Madison then carried out computational calculations on the electronic and structural properties of the intermediates that He observed in his experiments. The calculations showed that the bizarrely behaving intermediate was “zwitterionic,” meaning that it carried an overall neutral charge, but displayed positive or negative charges when interacting with different atoms.

“We were able to show that the intermediate captured by Chuan’s beautiful experiment is zwitterionic in nature, which offers new clues regarding the chemical steps of the biological demethylation process,” said Qiang Cui, professor of chemistry at UW-Madison.

The team documented the role of oxidation in demethylation using the U.S. Department of Energy’s Advanced Photon Source at Argonne National Laboratory. The APS produces the brightest X-rays in the Western Hemisphere, which permitted the team to determine the crystal structures that show the three-dimensional atomic framework of the intermediate stage in the demethylation process.

Members of He’s research team visit the APS two or three times a month for a full day of experimentation. “We literally collected close to a hundred data sets there,” He said. The researchers take multiple data sets at different intervals to confirm the accuracy of their results.

Latest News

IGSB Fellow Yoav Gilad heads study on how social stress changes immune system gene expression in primates

“We were able to use gene expression to classify individuals based on their rank,” said Yoav Gilad, PhD, associate professor of human genetics at the University of Chicago Biological Sciences and senior author of the study in PNAS. “Demonstrating these very plastic and temporal changes was novel and quite interesting.” Press Release

UChicago scientists find untapped potential in the “microbiome” of bacteria inside the human body

While microbiologists were classically limited to studying only bacterial species they could get to grow in a laboratory dish, the new method of metagenomics has allowed ecologists to discover thousands of new species in a single scoop of soil or teaspoon of seawater. Now that technology is being applied by University of Chicago Medicine researchers, in collaboration with Argonne National Laboratory, to the ecosystem of the human gut.Press Release

IGSB Senior Fellow Janet Rowley wins the 2012 Japan Prize for Healthcare and Medical Technology

Janet Davison Rowley, MD, the Blum-Riese Distinguished Service Professor of Medicine, Molecular Genetics & Cell Biology and Human Genetics at the University of Chicago, will share the 2012 Japan Prize for Healthcare and Medical Technology with Brian J. Druker, MD, from the Oregon Health and Science University, and Nicholas B. Lydon, PhD, formerly with Novartis. They were chosen for their roles in the development of the first precisely targeted anti-cancer drug, called imatinib (Gleevec®). Press Release

IGSB Fellow Habibul Ahsan receives named professorship

Habibul Ahsan, MD, MMedSc, professor in the departments of health studies, human genetics and medicine, director of the Center for Cancer Epidemiology and Prevention at the University of Chicago Medical Center and associate director of the University of Chicago Comprehensive Cancer Center, has been named a Louis Block Professor. Press Release

Top Japanese Scientist leaving government post to move to the University of Chicago Medical Center

“Dr. Nakamura has made major contributions to modern genetics and genomics,” said Kenneth Polonsky, MD, Dean of the Biological Sciences Division and the Pritzker School of Medicine at the University of Chicago. “We are extremely gratified by his interest in continuing his illustrious career at the University of Chicago.”  Press Release

IGSB Core Faculty Robert Grossman appointed Chief Research Informatics Officer of the Division of the Biological Sciences

Robert Grossman, PhD, assumed the role of chief research informatics officer and is currently overseeing a research group focused on bioinformatics, data mining, data intensive computing and related areas. Press Release

Subscribe to RSS Feed